China's tightened annual fine particulate matter (PM2.5) standard could substantially reduce premature deaths and move the country closer to the World Health Organization's 2040 goal of halving air-pollution-related mortality, according to a new health impact assessment published online 23 October 2026 in Environmental Science and Ecotechnology.
The study, led by researchers at Peking University Health Science Center and the Chinese Academy of Environmental Planning, estimates that full compliance with China's revised 25 micrograms per cubic meter (µg m⁻³) annual PM2.5 limit would have averted an estimated 233,668 premature deaths in 2024, a 16.1% reduction from observed levels. In contrast, the former 35 µg m⁻³ standard would have averted 53,985 deaths. The stricter limit would expand the population above the regulatory threshold from 33% to 65%.
China introduced a 35 µg m⁻³ annual PM2.5 limit in 2012 and later cut population-weighted exposure from 62.8 to 29.7 µg m⁻³ between 2013 and 2024 through clean air actions. In 2026, China revised its National Ambient Air Quality Standards to 25 µg m⁻³, with an interim 30 µg m⁻³ phase from 2026 to 2030. The "Beautiful China Initiative" targets below 25 µg m⁻³ by 2035.
The health gains are strongly disease-specific. Under the 25 µg m⁻³ scenario, mortality fell by 22.8% for chronic obstructive pulmonary disease (COPD), 18.4% for stroke, 18.4% for lung cancer, 18.0% for lower respiratory infections and 16.0% for ischemic heart disease. Reductions were only 1.4% for dementia and 1.1% for type 2 diabetes mellitus; the dementia estimate requires caution because evidence is weaker.
Nationally, the PM2.5-attributable fraction of mortality fell from 32.5% in 2015 to 22.6% in 2024. Full compliance with 35, 30 and 25 µg m⁻³ would increase PM2.5-specific progress toward the WHO halving target to 66.2%, 72.6% and 83.4%, respectively. COPD would exceed the 50% halving benchmark under the 25 µg m⁻³ scenario, whereas dementia and type 2 diabetes would remain far behind.
A sensitivity analysis using the Global Exposure Mortality Model for non-communicable diseases and lower respiratory infections showed a similar pattern, with 3.9 times more deaths averted under 25 than 35 µg m⁻³.
The findings support health-oriented implementation of China's revised standards. Policymakers could prioritize regions with large populations and high PM2.5 exposure, where compliance with 25 µg m⁻³ would yield the largest gains, and pair air-quality control with older-adult protection, clinical prevention and chronic-disease management. Because abatement costs are rising and population aging can offset exposure-related gains, future standards should be evaluated by disease-specific health returns, not compliance rates alone.
The framework could inform other developing countries seeking to tighten PM2.5 limits while tracking progress toward the WHO 2040 halving target. The study is available at 10.1016/j.ese.2026.100781.
